Biontech stock.

Mar 20, 2024 ... BioNTech said that writedowns of inventory from its partner Pfizer (PFE) lowered revenue by 291.3 million euros ($315.9 million) in the quarter.

Biontech stock. Things To Know About Biontech stock.

BioNTech, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock decline by about 2% over the last week (five trading days) and also remains down by about ...BioNTech SE (BNTX) is a publicly traded biotechnology business based in the US. It opened the day at $92.56 after a previous close of $91.67. During the day the price has varied from a low of $92.4132 to a high of $93.48. The latest price was $92.72 (25 minute delay). BioNTech is listed on the NASDAQ and employs 6,133 staff.Shares of BioNTech SE dropped 2.4% toward a three-month low in premarket trading ... The stock has sunk 29.1% year to date through Friday while Pfizer shares have lost 31.7% and the S&P 500 ...BioNTech, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock decline by almost 9.4% over the last week (five trading days) and by about 17% over the ...

Find out all the key statistics for BioNTech SE (BNTX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ... Stock Price History. Beta (5Y ...

Stock analysis for BioNTech SE (22UA:Xetra) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

When it comes to building a well-stocked kitchen, having the right tools and essentials is essential. Whether you’re an avid home cook or just starting out in the culinary world, h...Particularly in BioNTech's oncology pipeline, there will soon be enough mid-stage clinical projects approaching critical readouts to make predicting the stock's price an exercise in futility.In my view, it isn't too late to buy BioNTech stock whatsoever, and here's why. Right now, it has 2.3 billion euros in cash, and only 286 million euros in debt. And its trailing 12-month operating ...4 days ago · 11 brokers have issued 12 month price targets for BioNTech's shares. Their BNTX share price targets range from $90.00 to $171.00. On average, they expect the company's stock price to reach $118.82 in the next year. This suggests a possible upside of 28.1% from the stock's current price.

Bp rewards

On average, Wall Street analysts predict. that Biontech Se's share price could reach $113.57 by May 8, 2025. The average Biontech Se stock price prediction forecasts a potential upside of 23.37% from the current BNTX share price of $92.06.

Get the latest BioNTech SE - ADR (22UA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Still, the brothers are poised to lock in major gains after first providing BioNTech with €150 million ($186 million) in seed money when it was founded in 2008. The shares have climbed more than ...BioNTech SE. An der Goldgrube 12. 55131 Mainz, Deutschland. T: +49 6131 9084-0. F: +49 6131 9084-2121. [email protected]. Unternehmen. Über uns Forschung & Innovation Unsere Pipeline Produktion Karriere COVID-19. Quick Links. News Investoren Medizinisches Fachpersonal Connect.BioNTech stock, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, declined by almost 31% over the last month, considerably underperforming the S&P 500 which remained ...BioNTech Stock History. Headquartered in Mainz, Germany, BioNTech is a pharmaceutical company with a history dating back to 2008. Prior to its partnership with Pfizer, the company specialized in ...Monday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss of 97 cents. The COVID-19 vaccine ...

BNTX Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View BioNTech SE Sponsored ADR BNTX stock quote prices, financial information, real-time forecasts, and company news from CNN.Get Biontech SE (BNTX.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsWhy BioNTech Stock Was Sinking Today. Why Shares of BioNTech Rose Friday. 2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years. Why Shares of BioNTech Slumped Monday.BioNTech, founded in 2008 by Ugur Sahin and Özlem Türeci, is a German biotechnology company focused on developing individualized cancer immunotherapies and mRNA vaccines. The company's ...BioNTech stock, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, declined by almost 31% over the last month, considerably underperforming the S&P 500 which remained ...VIENNA STOCK EXCHANGE - BIONTECH SE ADR stocks (ISIN: US09075V1026) - price data, chart, performance & dividend for BIONTECH SE ADR. Q1 2024 BioNTech SE Earnings Call. Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Moderna and BioNTech are no longer minting money from Covid vaccines. But both have strong drug pipelines and plenty of cash.The company affirmed its full-year guidance of revenue between EUR2.5 billion and EUR3.1 billion ($2.7 billion and $3.3 billion). BioNTech ADRs have lost about …

Discover historical prices for BNTX stock on Yahoo Finance. View daily, weekly or monthly format back to when BioNTech SE stock was issued.0. 0. In the last 3 months, 5 analysts have offered 12-month price targets for BioNTech. The company has an average price target of $129.0 with a high of $180.00 and a low of $110.00. Below is a ...The average analyst rating for BioNTech SE stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market ...BioNTech SE (BNTX) ADS. BioNTech SE (BNTX) Sell: $92.56 Buy: $92.74 $1.05 (1.15%) NASDAQ: 0.29%. Market closed | Prices as at close on 13 May 2024 | Turn off streaming prices. Add to watchlist ...BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June …Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...BioNTech's stock has underperformed the broader market as it is off 27% in the last year compared to the SP500 being up 32%. StockCharts.com. Per Fintel, BioNTech's short interest makes up 3.38% ...Monday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss of 97 cents. The COVID-19 vaccine ...Aug 7, 2023 · BNTX stock analysts projected a per-share loss of 30 cents. BioNTech blamed write-offs to partner Pfizer for the profit and sales hits. On today's stock market, BNTX stock toppled 7.5% to 98.50 ...

12 days a slave

Cash Amount. Record Date. Pay Date. Jun 2, 2022. $2.111. Jun 3, 2022. Jun 17, 2022. * Dividend amounts are adjusted for stock splits when applicable. Get the latest dividend data for BioNTech SE (BNTX), including dividend history, yield, key dates, growth and other metrics.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $116.6, a high estimate of $133.00, and a low estimate of $99.00. Experiencing a 11.83% decline, the ...MAINZ, Germany, March 11, 2024 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data for selected candidates from its oncology pipeline at the ...BioNTech, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock decline by almost 9.4% over the last week (five trading days) and by about 17% over the ...BioNTech stock (NASDAQ: BNTX), a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, declined by almost 31% over the last month, considerably underperforming the S&P 500 ...Apr 12, 2024 · Discover real-time BioNTech SE American Depositary Share (BNTX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq. BioNTech has agreed to buy UK artificial intelligence start-up InstaDeep for up to £562mn in its biggest-ever deal, as the German company expands beyond the Covid-19 vaccine that transformed its ...Find the latest BioNTech SE (22UA.DE) stock quote, history, news and other vital information to help you with your stock trading and investing.BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies includ ing mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or ...Dec 28, 2023 · BioNTech, like all Covid-19 vaccine makers, has gotten crunched in 2023. But it has so much cash that it would have appealed to Warren Buffett’s mentor, famed value manager Benjamin Graham. BioNTech ended 2023 with approximately €17.5 billion (unaudited) in cash, cash equivalents and security investments. The Company plans to maintain a strong financial position and generate ...

Stock analysis for BioNTech SE (BNTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Complete BioNTech SE ADR stock information by Barron's. View real-time BNTX stock price and news, along with industry-best analysis.May 10, 2024 · BioNTech’s stock sinks after earnings miss, as inventory writedowns weigh Mar. 20, 2024 at 7:30 a.m. ET by Tomi Kilgore Biontech 4Q Rev EUR1.48B Instagram:https://instagram. optim performance manager BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for … stream free sports BioNTech shows promising future growth and profitability despite a projected decline in vaccine revenues in Q2 2023. Read why I'm bullish on BNTX stock. Find the latest BioNTech SE (BNTX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. qr code scanner for pc Answering this question will take us one step closer to our new normal. We know that the vaccines now available across the world will protect their recipients from getting sick wit...BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript Motley Fool - Wed Mar 20, 1:45PM CDT. BNTX earnings call for the period ending December 31, 2023. BNTX : 93.04 (+1.49%) 3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024 Motley Fool - Mon Dec 18, 2023. lg apps Jan 9, 2024 · Get Biontech SE (BNTX.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments BioNTech Stock History. Headquartered in Mainz, Germany, BioNTech is a pharmaceutical company with a history dating back to 2008. Prior to its partnership with Pfizer, the company specialized in ... boise to phoenix Mar 20, 2024 · The high end of the outlook lagged BioNTech stock analysts' forecast for $3.37 billion, according to FactSet. In response, BioNTech stock dropped to its lowest point since January 2021 ... convert gps coordinates BioNTech SE (BNTX) is a publicly traded biotechnology business based in the US. It opened the day at $92.56 after a previous close of $91.67. During the day the price has varied from a low of $92.4132 to a high of $93.48. The latest price was $92.72 (25 minute delay). BioNTech is listed on the NASDAQ and employs 6,133 staff. direction of al kaaba Find the latest BioNTech SE (BNTX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Get the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies includ ing mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific … plane tickets from chicago to new york According to the issued ratings of 11 analysts in the last year, the consensus rating for BioNTech stock is Hold based on the current 1 sell rating, 6 hold ratings and 4 buy ratings for BNTX. The average twelve-month price prediction for BioNTech is $117.25 with a high price target of $171.00 and a low price target of $90.00. youtube movies BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies includ ing mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or ... how can we pronounce BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript. Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. cancel flight BioNTech SE. An der Goldgrube 12. 55131 Mainz, Germany. T: +49 6131 9084-0 F: +49 6131 9084-2121 [email protected]. CompanyNov 6, 2023 · (RTTNews) - BioNTech SE (BNTX) Monday announced a sharp fall in third-quarter earnings compared to the prior year, as the commercial revenues were down sharply. The company revised down its COVID ... BioNTech: The Novavax Fork In The Road. A high-level overview of BioNTech SE (BNTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.